Abstract

Public concerns over the use of synthetic pesticides are growing since many studies have shown their impact on human health. A new environmental movement in occidental countries promoting an organic agriculture favours the rebirth of botanical pesticides. These products confer an effective alternative to chemical pesticides such as glyphosate. Among the biopesticides, the α-terthienyls found in the roots of Tagetes species, are powerful broad-spectrum pesticides. We found that an α-terthienyl analogue with herbicidal properties, called A6, triggers resistant SDS oligomers of the pathogenic prion protein PrPSc (rSDS-PrPSc) in cells. Our main question is to determine if we can induce those rSDS-PrPSc oligomers in vitro and in vivo, and their impact on prion aggregation and propagation. Using wild-type mice challenged with prions, we showed that A6 accelerates or slows down prion disease depending on the concentration used. At 5 mg/kg, A6 is worsening the pathology with a faster accumulation of PrPSc, reminiscent to soluble toxic rSDS-PrPSc oligomers. In contrast, at 10 and 20 mg/kg of A6, prion disease occurred later, with less PrPSc deposits and with rSDS-PrPSc oligomers in the brain reminiscent to non-toxic aggregates. Our results are bringing new openings regarding the impact of biopesticides in prion and prion-like diseases.

Details

Title
Low doses of bioherbicide favour prion aggregation and propagation in vivo
Author
Pierre-André Lafon 1 ; Imberdis, Thibaut 2   VIAFID ORCID Logo  ; Wang, Yunyun 3 ; Torrent, Joan 1 ; Robitzer, Mike 4 ; Huetter, Elisabeth 1 ; Alvarez-Martinez, Maria-Teresa 5 ; Chevallier, Nathalie 1 ; Givalois, Laurent 1 ; Desrumaux, Catherine 1 ; Liu, Jianfeng 6 ; Perrier, Véronique 1   VIAFID ORCID Logo 

 MMDN, University Montpellier, EPHE, INSERM, U1198- EiAlz team, PSL Research University, Montpellier, France 
 MMDN, University Montpellier, EPHE, INSERM, U1198- EiAlz team, PSL Research University, Montpellier, France; Ann Romney Center for Neurologic Diseases, Brigham and Women’s hospital, Harvard Medical School, Boston, MA, USA 
 MMDN, University Montpellier, EPHE, INSERM, U1198- EiAlz team, PSL Research University, Montpellier, France; Cellular Signaling Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, China 
 Institut Charles Gerhardt Montpellier, UMR 5253 CNRS-ENSCM-UM, Matériaux Avancés pour la Catalyse et la Santé, Montpellier, France 
 Etablissement Confiné d’Expérimentation A3/L3, CECEMA, US009 Biocampus, UMS 3426, Université Montpellier, Montpellier, France 
 Cellular Signaling Laboratory, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, China 
Pages
1-14
Publication year
2018
Publication date
May 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2043151742
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.